Pathophysiology of Hyperparathyroidism and Tendon Rupture
Hyperparathyroidism causes tendon rupture through PTH-mediated osteolytic bone resorption at tendon insertion sites (entheses), weakening the bone-tendon interface and leading to spontaneous rupture, particularly when PTH levels exceed 600 pg/mL. 1, 2
Mechanism of Tendon Failure
The pathophysiologic link between hyperparathyroidism and tendon rupture operates through enthesis failure rather than primary tendon degeneration 3, 4, 5:
- Elevated PTH drives osteoclastic bone resorption at the tendon insertion sites, creating a weakened bone-tendon junction 4, 5
- The bone resorption undermines the structural integrity of the enthesis, making it vulnerable to failure even without significant trauma 3
- This represents a form of metabolic bone disease affecting the skeletal attachment points rather than the tendon substance itself 6
Critical PTH Threshold
PTH levels ≥600 pg/mL dramatically increase tendon rupture risk 2:
- Incidence of tendon rupture: 0.0199 per person-year (1 case per 50 patient-years) when PTH ≥600 pg/mL 2
- Incidence drops to essentially zero (0 per 5202 patient-years) when PTH <600 pg/mL 2
- The mean PTH level in patients with tendon rupture was 2025.7 ± 667.6 pg/mL versus 1728.4 ± 684.8 pg/mL in those without rupture 1
Associated Metabolic Derangements
Beyond PTH elevation, several metabolic factors contribute to the pathophysiology 1, 2:
- Hyperphosphatemia (mean 6.3 ± 1.5 mg/dL in rupture patients vs 5.6 ± 1.1 mg/dL without) exacerbates bone disease 1
- Elevated inflammatory markers (CRP 35.4 ± 32.9 mg/dL vs 17 ± 24.5 mg/dL) suggest systemic inflammation contributes to tissue vulnerability 1
- High bone turnover reflected by elevated alkaline phosphatase indicates active osteoclastic resorption at entheses 2
Bone Histology Context
The underlying bone pathology in hyperparathyroidism provides the structural basis for tendon rupture 6:
- Osteitis fibrosa develops with increases in osteoclasts, osteoblasts, and fibroblasts causing abnormal bone resorption and formation 6
- Marrow fibrosis accompanies the hyperparathyroid bone changes 6
- This high-turnover bone disease creates focal areas of weakness at tendon insertion sites 6
Clinical Implications
Tendon rupture serves as a "red flag" for severe metabolic bone disease 1:
- Patients with tendon rupture have 2.87 times higher risk of subsequent hip fracture (HR 2.87,95% CI 1.27-6.49) 1
- Hip fractures occur approximately 29.5 months after tendon rupture 1
- The combined incidence of tendon rupture and fracture reflects the severity of hyperparathyroidism control 2
Prevention Through PTH Control
Parathyroidectomy reduces tendon rupture risk by lowering bone turnover 2, 4, 5:
- Reduction in alkaline phosphatase post-parathyroidectomy associates with lower tendon rupture risk 2
- Control of secondary hyperparathyroidism through vitamin D analogs or parathyroidectomy prevents progression of osteolytic changes 4, 5
- Early intervention before PTH exceeds 600 pg/mL appears protective 2
Common Pitfall
A critical error is attributing tendon ruptures solely to tendon pathology or local factors (prior corticosteroid/fluoroquinolone use) while missing the underlying systemic metabolic bone disease 4, 7. The primary pathology is at the bone-tendon interface, not within the tendon itself 3. This distinction is crucial because treatment must address the metabolic bone disease through PTH control, not just surgical tendon repair 4, 5.